Web-Based Exercise Program for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a web-based exercise program called the PATH intervention to help adults with obesity become more active. Participants will either use the PATH program or join an attention control group, which involves behavioral pain management strategies and later access to the program. The researchers aim to determine if this online approach can motivate people with obesity, who aren't meeting activity guidelines, to increase their physical activity. Ideal candidates for this trial have a BMI of 30 or higher, do not currently exercise for at least 150 minutes a week, and have regular internet access. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could lead to new ways to support healthier lifestyles.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the PATH program is safe for people with obesity. Studies have found that adults with overweight or obesity find the program easy to follow and acceptable. Participants in earlier trials did not report any major problems. The program encourages increased physical activity, which is generally safe for most adults. However, starting a new exercise routine can sometimes cause minor issues like sore muscles. Consulting a healthcare provider before beginning is always advisable. Overall, research suggests that the PATH program is well-tolerated and safe.12345
Why are researchers excited about this trial?
Researchers are excited about the PATH Intervention for obesity because it offers a web-based exercise program specifically tailored for individuals who are insufficiently active. Unlike traditional treatments like diet modifications, medication, or in-person fitness plans, PATH provides flexibility and accessibility through an online platform, making it easier for participants to integrate into their daily lives. This innovative approach empowers users to engage with the program on their own schedule, potentially increasing adherence and effectiveness. By combining digital convenience with personalized exercise guidance, PATH aims to tackle obesity in a way that fits seamlessly into modern lifestyles.
What evidence suggests that this trial's treatments could be effective for obesity?
Research has shown that online exercise programs, such as the PATH intervention included in this trial, can assist with weight management. One study found that these digital exercise programs help adults lose weight and reduce body fat. Another study demonstrated that online group programs significantly aid in weight loss. Additionally, people generally find these online programs easy to use and helpful. Overall, this suggests that the PATH intervention could be a promising method for helping individuals with obesity manage their weight. Participants in this trial may also join the Attention Control Group, which will receive access to the PATH program at the study's conclusion.678910
Who Is on the Research Team?
Jacob Kariuki, PhD, NP
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for adults with obesity who are not very active, have a BMI of 30 or higher, and don't exercise much (less than 150 minutes of moderate activity per week). They must be able to use the internet regularly and track their physical activity. People can't join if they're pregnant, planning to get pregnant soon, have mobility issues, need supervised exercise due to certain conditions like stroke or heart disease unless cleared by a doctor.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either the PATH intervention or the attention control group for 6 months
Follow-up
Participants are monitored for changes in physical activity and health metrics after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control Intervention
- Dietary education
- PATH Intervention
- Physical activity tracker
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator